Latest News and Press Releases
Want to stay updated on the latest news?
-
IMMUNE THERAPEUTICS STRENGTHENS BALANCE SHEET; Reiterates Outlook for Positive Cash Flow by Mid Year
ORLANDO, Fla., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and...
-
Immune Therapeutics Receives Approval for Lodonal™ from theDominican Republic’s Ministry of Health and Social Assistance ORLANDO, Fla., Feb. 02, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics,...
-
Company Expects to Report Initial Revenues in First Half of 2017 and Achieve Profitability by Year-End Company to Host Investor Conference Call to Discuss Positive Developments ORLANDO, Fla.,...
-
Company Expects to Report Initial Revenues in First Half of 2017 and Achieve Profitability by Year-End Company to Host Investor Conference Call to Discuss Positive Developments ORLANDO, Fla.,...
-
ORLANDO, Fla., Jan. 27, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and...
-
ORLANDO, Fla., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN) a clinical-stage biotech company providing immunotherapy solutions for the treatment of autoimmune...
-
ORLANDO, Fla., June 15, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biotech company providing immunotherapy solutions for the treatment of infectious and...
-
ORLANDO, Fla., May 18, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biotech company providing immunotherapy solutions for the treatment of infectious and...
-
ORLANDO, Fla., April 27, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN) (the “Company”), a clinical-stage biotech company providing immunotherapy solutions for the treatment...